There are many stories of individual weight loss success
PMID: 16284430 [5] Andrs E, et al
Safety, Eligibility, and Provider-Guided Decision-Making GLP-1 medications are not appropriate for everyone
Hypoglycaemiagenerally defined as blood glucose below 4.0 mmol/Ltriggers a counter-regulatory response involving adrenaline release, which produces symptoms including sweating, tremor, palpitations, and dizziness
The transmembrane FNDC5 is a precursor of the recently identified hormone irisin that possesses a range of bioactivities, including anti-obesity and anti-diabetes
This information helps providers distinguish between expected medication effects, coincidental illnesses, and potential adverse reactions requiring intervention